LIVE! Testing Board®: Breaking Down Pathologic Reports to Identify Actionable Markers in Patients with NSCLC

Welcome, Introductions, Pre-Session Survey

The Role of Biopsy and Testing Technology in NSCLC: Current Options

Trial Updates and Emerging Biomarkers in Advanced NSCLC

Case #1: Patient with resected stage II NSCLC found to have an ALK rearrangement

Case #2: Molecular Testing in a Patient with Acquired Resistance to EGFR TKI Therapy

Case #3: Patient with malignant pleural effusion relatively uninformative plasma biopsy

Case #4: Never Smoker With NSCLC Has a Bone Biopsy; Decision Making Around Liquid Biopsy

Case #5: Patient with ROS1-positive NSCLC